A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
Status:
Active, not recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety, tolerability, pharmacokinetic (PK), and
comparative bioavailability of repeated administration of GSBR-1290 in healthy
overweight/obese participants.